June 2016

home / publications / contemporary-radiation-oncology / june-2016

Radiation Dose Escalation to the Tumor-Arterial Interface of Locally Advanced and Borderline Resectable Pancreatic Cancer

Martin C. Tom, MD;Eugene J. Koay, MD, PhD, MD Anderson Cancer Center;Priya Bhosale, MD;Prajnan Das, MD, MPH;Matthew H. Katz, MD;Jason B. Fleming, MD;Jeffrey E. Lee, MD;Gauri R. Varadhachary, MD;Robert A. Wolff, MD;Christopher H. Crane, MD

July 9th 2016

Article

An integrated boost with conventional fractionation to the tumor-arterial interface is unlikely to lead to downstaging in borderline resectable and locally advanced pancreatic cancer.

eContour: Evidence-Based Interactive Contouring Resources at the Point of Care

Erin F. Gillespie, MD, Neil Panjwani, BS, Arno J. Mundt, MD;James D. Murphy, MD, MS

June 25th 2016

Article

eContour is a novel, web-based, interactive contouring resource that aims to facilitate access to decision support through high-yield radiation treatment recommendations that are free and available at the point of care.

$Hypofractionated and Stereotactic Body Radiotherapy in Prostate Cancer$

Hypofractionated and Stereotactic Body Radiotherapy in Prostate Cancer

Chirag Shah, MD;Kevin Stephans, MD;Aditya Juloori, MD;Andrew Vassil, MD;Constantine Mantz, MD;Alvaro Martinez, MD;Frank Vicini, MD;Eduardo Fernandez, MD;Rahul D. Tendulkar, MD;Steven E. Finkelstein, MD

June 20th 2016

Article

Despite limited data comparing stereotactic body radiation therapy to standard or hypofractionated radiotherapy with regards to long-term clinical outcomes and toxicity profiles, the data are promising and appropriately selected patients can be offered such an approach off-protocol.

Shooting for the Moon…and Beyond

Steven Eric Finkelstein, MD

June 6th 2016

Article

This is an exciting time, as reports of major news impacting oncology research are emerging, it seems, on a daily basis.

Driving Change for the Future of Radiation Oncology

Mike Hennessy

June 5th 2016

Article

As we approach the 1-year anniversary of Contemporary Radiation Oncology (CRO) publication, it occurs to me, upon reflection, how much change has occurred in the utilization of radiation oncology for cancer treatment in recent months.